A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis
Yıl: 2021 Cilt: 30 Sayı: 2 Sayfa Aralığı: 176 - 178 Metin Dili: İngilizce DOI: 10.5152/turkjnephrol.2021.4454 İndeks Tarihi: 14-10-2021
A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis
Öz: Elephantiasis nostras verrucosa (ENV) is a rare, chronic, and progressive disease. Recurrent leg ulcers and cellulitis are the major cause of morbidity and mortality for ENV. However, the coexistence of ENV with AA amyloidosis is extremely rare. Also, obesity is exceptionally responsible for the etiology of ENV. Herein, We present a morbid obese case of severe kidney failure and nephrotic syndrome due to AA amyloidosis associated with ENV.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1. Lymphatic filariasis; WHO's work on lymphatic filariasis. https:// www.who.int/news-room/fact-sheets/detail/lymphatic-filari asis.
- 2. Sisto K, Khachemoune A. Elephantiasis nostras verrucosa: a review. Am J Clin Dermatol. 2008;9(3):141-146. [CrossRef]
- 3. Tatar E, Tasli F, Alpay H, et al. A patient with renal AA amyloidosis following pulmonary squamous cell carcinoma: case report and literature review. Turk J Nephrol. 2019;28(3):225-228. [CrossRef]
- 4. Atilgan KG, Odabas AR , Dede F, Ayli MD. Analysis of clinical and laboratory findings of secondary amyloidosis. Turk J Nephrol. 2018;27:267-271.
- 5. Beloncle F, Sayegh J, Eymerit-Morin C, Duveau A, Augusto JF. AA Amyloidosis as a complication of primary lymphedema. J Protein Folding Disord Amyloid. 2014;21(1):54-56. [CrossRef]
- 6. Rodriguez I,Garza J,Chapa J, Ocampo-Candiani J. Elephantiasis nostras verrucosa as a manifestation of morbid obesity . BMJ Case Rep. 2014;18;bcr2014207574.
- 7. Nayak HK, Daga MK, Garg SK, et al. A rare case of reversible acquired AA-type renal amyloidosis in a chronic filariasis patient receiving antifilarial therapy. Clin Exp Nephrol. 2011;15(4):591-595. [CrossRef]
- 8. Kovesdy CP, Furth S ,Zoccalı C. Obesity and kidney disease: hidden consequences of the epidemic. Turk J Nephrol. 2017;26:1-10.
- 9. Blank N, Hegenbart U, Dietrich S, et al. Obesity is a significant susceptibility factor for idiopathic AA amyloidosis. Amyloid. 2018;25(1):37-45. [CrossRef]
- 10. Stankovic Stojanovic K, Georgin-Lavialle S, Poitou C, et al. AA amyloidosis is an emerging cause of nephropathy in obese patients. Eur J Intern Med. 2017;39:e18-e20. [CrossRef]
APA | SARI K, Vatansever B, aktar m, Soyhan M, NAMDAROGLU S, Özkök G, tatar e (2021). A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis. , 176 - 178. 10.5152/turkjnephrol.2021.4454 |
Chicago | SARI Kerime Rümeysa,Vatansever Bulent,aktar merve,Soyhan Merve,NAMDAROGLU SİNEM,Özkök Güliz,tatar erhan A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis. (2021): 176 - 178. 10.5152/turkjnephrol.2021.4454 |
MLA | SARI Kerime Rümeysa,Vatansever Bulent,aktar merve,Soyhan Merve,NAMDAROGLU SİNEM,Özkök Güliz,tatar erhan A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis. , 2021, ss.176 - 178. 10.5152/turkjnephrol.2021.4454 |
AMA | SARI K,Vatansever B,aktar m,Soyhan M,NAMDAROGLU S,Özkök G,tatar e A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis. . 2021; 176 - 178. 10.5152/turkjnephrol.2021.4454 |
Vancouver | SARI K,Vatansever B,aktar m,Soyhan M,NAMDAROGLU S,Özkök G,tatar e A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis. . 2021; 176 - 178. 10.5152/turkjnephrol.2021.4454 |
IEEE | SARI K,Vatansever B,aktar m,Soyhan M,NAMDAROGLU S,Özkök G,tatar e "A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis." , ss.176 - 178, 2021. 10.5152/turkjnephrol.2021.4454 |
ISNAD | SARI, Kerime Rümeysa vd. "A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis". (2021), 176-178. https://doi.org/10.5152/turkjnephrol.2021.4454 |
APA | SARI K, Vatansever B, aktar m, Soyhan M, NAMDAROGLU S, Özkök G, tatar e (2021). A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis. Turkish journal of nephrology (Online), 30(2), 176 - 178. 10.5152/turkjnephrol.2021.4454 |
Chicago | SARI Kerime Rümeysa,Vatansever Bulent,aktar merve,Soyhan Merve,NAMDAROGLU SİNEM,Özkök Güliz,tatar erhan A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis. Turkish journal of nephrology (Online) 30, no.2 (2021): 176 - 178. 10.5152/turkjnephrol.2021.4454 |
MLA | SARI Kerime Rümeysa,Vatansever Bulent,aktar merve,Soyhan Merve,NAMDAROGLU SİNEM,Özkök Güliz,tatar erhan A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis. Turkish journal of nephrology (Online), vol.30, no.2, 2021, ss.176 - 178. 10.5152/turkjnephrol.2021.4454 |
AMA | SARI K,Vatansever B,aktar m,Soyhan M,NAMDAROGLU S,Özkök G,tatar e A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis. Turkish journal of nephrology (Online). 2021; 30(2): 176 - 178. 10.5152/turkjnephrol.2021.4454 |
Vancouver | SARI K,Vatansever B,aktar m,Soyhan M,NAMDAROGLU S,Özkök G,tatar e A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis. Turkish journal of nephrology (Online). 2021; 30(2): 176 - 178. 10.5152/turkjnephrol.2021.4454 |
IEEE | SARI K,Vatansever B,aktar m,Soyhan M,NAMDAROGLU S,Özkök G,tatar e "A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis." Turkish journal of nephrology (Online), 30, ss.176 - 178, 2021. 10.5152/turkjnephrol.2021.4454 |
ISNAD | SARI, Kerime Rümeysa vd. "A Rare Complication of Morbid Obesity:Elephantiasis Nostras Verrucosa and Amyloidosis". Turkish journal of nephrology (Online) 30/2 (2021), 176-178. https://doi.org/10.5152/turkjnephrol.2021.4454 |